Japanese Journal of Chemotherapy
Online ISSN : 1884-5886
Print ISSN : 1340-7007
ISSN-L : 1340-7007
Primary central nervus system lymphoma developing methotrexate pneumonitis due to high-dose treatment
Yutaka TakeiNoriko UsuiTakeshi HaginoYutaka OkawaKatsuki SugiyamaShinji UnoNobuaki DobashiMasayuki Kobayashi
Author information
JOURNAL FREE ACCESS

2003 Volume 51 Issue 12 Pages 758-761

Details
Abstract

A 58-year-old man admitted for gaitdisturbance and dysarthria was fbund in postcontrast MRI of the brain to have a hyperintense mass in the splenium of the corpus callosum and around bilateral deep white matter. Ile was referred to the department of neurosurgery in July 2002. Brain tumor biopsy showed diff'use large B cell lymphoma, and he was diagnosed with primary central nervous system lymphoma. After a ndergoing two courses of high-dose methotrexate chemtotherapy, he developed drug-induced pneumonitis with high lever, shortness of breath, and fine crackles, confirmed by drug lymphocyte stimulation tests. Alter steroid pulse therapy, his pneumonitis markedly improved. Therefore, it is important that patients receiving rnethotrexate be carefully watched for adverse pulmonary effects.

Content from these authors
© Japanese Society of Chemotherapy
Previous article Next article
feedback
Top